Atossa Therapeutics, Inc. (ATOS)

NCM – Real Time Price. Currency in USD

2.29

-0.07 (-3.02%)

Market open: Aug 12, 2026, 10:04 AM EDT

2.39

+0.03 (1.27%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

07.08.2026

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced its financial results and provided an update on recent corporate developments for the second quarter ended June 30, 2026. "During the quarter, we executed well across the business," stated Dr. Steven Quay, M.D.

Videos

No Data

There is no data to display

Press releases

07.08.2026

Atossa Therapeutics, Inc. (ATOS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Atossa Therapeutics, Inc. (ATOS)

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Videos

No Data

Press releases

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Videos

No Data

Press releases

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Search stocks

Atossa Therapeutics, Inc. (ATOS)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Atossa Therapeutics, Inc. (ATOS)

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Videos

No Data

Press releases

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update

Videos

No Data

Press releases

Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update